Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER). Gevaert P, Bachert C, Maspero JF, Cuevas M, et al. J Allergy Clin Immunol 2022 Jan 27. pii: S0091-6749(21)02599.

Read + Share

Amedeo Smart

Independent Medical Education

Gevaert P, Bachert C, Maspero JF, Cuevas M, et al. Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER). J Allergy Clin Immunol 2022 Jan 27. pii: S0091-6749(21)02599.
PMID: 35094848